NCT04168216View on ClinicalTrials.gov

Study of Relationship Between Changes in Inflammation, Lung Function, Symptoms and Medication Use in COPD Patients

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

June 22, 2022

Study Completion Date

June 22, 2022

Conditions
Pulmonary Disease, Chronic Obstructive
Trial Locations (1)

OX3 7LE

Research Site, Oxford

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

University of Oxford

OTHER

lead

AstraZeneca

INDUSTRY